SCHEMBL9250987

SCHEMBL9250987

N#Cc1ccc(CC(C(=O)O)(C(=O)O)C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.50
CTBP2 P56545 1/20 0.49
SAE1 Q9UBE0 1/20 0.46
UBA2 Q9UBT2 1/20 0.46
LOXL2 Q9Y4K0 2/20 0.45
CYP2A6 P11509 1/20 0.45
GSK3B P49841 1/20 0.43
MMP12 P39900 1/20 0.43
MMP13 P45452 1/20 0.43
CA2 P00918 3/20 0.42
CA1 P00915 2/20 0.42
MAPT P10636 1/20 0.42
EPHX2 P34913 1/20 0.42
SLC22A12 Q96S37 1/20 0.41
IDO1 P14902 1/20 0.41
PPARD Q03181 2/20 0.40
PPARA Q07869 2/20 0.40
MMP2 P08253 1/20 0.40
CA12 O43570 1/20 0.40
CA3 P07451 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7290869 0.81 HTT (0.47) HTTCTBP2SAE1UBA2LOXL2
SCHEMBL27945030 0.81 SLC22A12 (0.57) HTTCTBP2SAE1UBA2LOXL2
SCHEMBL28246736 0.80 SLC22A12 (0.56) HTTCTBP2SAE1UBA2LOXL2
SCHEMBL8694396 0.79 BLM (0.65) HTTCTBP2SAE1UBA2LOXL2
SCHEMBL6361552 0.75 ALDH1A1 (0.47) HTTCTBP2SAE1UBA2LOXL2
SCHEMBL6371871 0.74 CYP2A6 (0.47) HTTCTBP2SAE1UBA2LOXL2
SCHEMBL335492 0.74 CTBP2 (0.62) HTTCTBP2SAE1UBA2LOXL2
Bicarbonate SCHEMBL11748879 0.73 CA2 (0.61) HTTCTBP2CYP2A6GSK3BCA2
SCHEMBL1695664 0.73 LOXL2 (0.57) HTTCTBP2SAE1UBA2LOXL2
SCHEMBL10029148 0.73 CYP2A6 (0.46) HTTCTBP2SAE1UBA2LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5463071-A Tetrazole derivatives; useful for inhibiting undesirable cell aggregation DR. KARL THOMAE GMBH (DE) 1995-10-31 US disclosed